---All---
  • ---All---
  • Accession
  • Catalog #

ARHGAP24 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP13826b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP13826b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ARHGAP24 Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ8N264
Other AccessionNP_001020787.2, NP_112595.2, NP_001036134.1
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW84258 Da

ARHGAP24 Antibody (C-term) - Additional info

Gene ID 83478
Other Names
ARHGAP24; FILGAP; Rho GTPase-activating protein 24; Filamin-A-associated RhoGAP; RAC1- and CDC42-specific GTPase-activating protein of 72 kDa; Rho-type GTPase-activating protein 24; RhoGAP of 73 kDa; Sarcoma antigen NY-SAR-88; p73RhoGAP
Target/Specificity
This ARHGAP24 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 586-616 amino acids from the C-terminal region of human ARHGAP24.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
ARHGAP24 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

ARHGAP24 Antibody (C-term) - Protein Information

Name ARHGAP24
Synonyms FILGAP
Function
Rho GTPase-activating protein involved in cell polarity, cell morphology and cytoskeletal organization. Acts as a GTPase activator for the Rac-type GTPase by converting it to an inactive GDP-bound state. Controls actin remodeling by inactivating Rac downstream of Rho leading to suppress leading edge protrusion and promotes cell retraction to achieve cellular polarity. Able to suppress RAC1 and CDC42 activity in vitro. Overexpression induces cell rounding with partial or complete disruption of actin stress fibers and formation of membrane ruffles, lamellipodia, and filopodia. Isoform 2 is a vascular cell-specific GAP involved in modulation of angiogenesis
Cellular Location
Cytoplasm, cytoskeleton. Cell junction, adherens junction. Cell junction, focal adhesion. Cell projection Note=Localizes to actin stress fibers. In migrating cells, localizes to membrane lamellae and protusions
Tissue Location
Isoform 1 is widely expressed with a higher level in kidney. Isoform 2 is mainly expressed in endothelial cells

ARHGAP24 Antibody (C-term) - Related products

AP13826b: ARHGAP24 Antibody (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

ARHGAPs, such as ARHGAP24, encode negative regulators of Rho GTPases (see ARHA; MIM 165390), which are implicated in actin remodeling, cell polarity, and cell migration (Katoh and Katoh, 2004 [PubMed 15254788]).

REFERENCES

Horinouchi, M., et al. Pediatr Hematol Oncol 27(5):344-354(2010) Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Holm, H., et al. Nat. Genet. 42(2):117-122(2010) Pfeufer, A., et al. Nat. Genet. 42(2):153-159(2010) Nakamura, F., et al. PLoS ONE 4 (3), E4928 (2009) :